- Home
- NEO vs ACDC Comparison
NEO vs ACDC Comparison
Compare NEO & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- ACDC
- Stock Information
- Founded
- NEO 2001
- ACDC 2014
- Country
- NEO United States
- ACDC United States
- Employees
- NEO N/A
- ACDC N/A
- Industry
- NEO Precision Instruments
- ACDC Oilfield Services/Equipment
- Sector
- NEO Health Care
- ACDC Energy
- Exchange
- NEO Nasdaq
- ACDC Nasdaq
- Market Cap
- NEO 1.2B
- ACDC 1.1B
- IPO Year
- NEO 1999
- ACDC 2022
- Fundamental
- Price
- NEO $9.62
- ACDC $7.78
- Analyst Decision
- NEO Strong Buy
- ACDC Hold
- Analyst Count
- NEO 10
- ACDC 5
- Target Price
- NEO $19.78
- ACDC $7.60
- AVG Volume (30 Days)
- NEO 1.5M
- ACDC 548.3K
- Earning Date
- NEO 04-29-2025
- ACDC 03-06-2025
- Dividend Yield
- NEO N/A
- ACDC N/A
- EPS Growth
- NEO N/A
- ACDC N/A
- EPS
- NEO N/A
- ACDC N/A
- Revenue
- NEO $660,566,000.00
- ACDC $2,190,900,000.00
- Revenue This Year
- NEO $12.89
- ACDC N/A
- Revenue Next Year
- NEO $11.36
- ACDC $12.88
- P/E Ratio
- NEO N/A
- ACDC N/A
- Revenue Growth
- NEO 11.65
- ACDC N/A
- 52 Week Low
- NEO $8.98
- ACDC $5.16
- 52 Week High
- NEO $19.11
- ACDC $9.75
- Technical
- Relative Strength Index (RSI)
- NEO 41.15
- ACDC 58.73
- Support Level
- NEO $9.57
- ACDC $6.90
- Resistance Level
- NEO $10.37
- ACDC $7.81
- Average True Range (ATR)
- NEO 0.65
- ACDC 0.42
- MACD
- NEO 0.13
- ACDC 0.12
- Stochastic Oscillator
- NEO 31.79
- ACDC 80.14
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.